CXCR4 and Miyoshi myopathy: [68Ga]Pentixafor(CXCR4 antagonist)-PET/CT can improve the detection rate of extramedullary lesions in MM patients compared with [18 F]FDG-PET/CT [14], and [68Ga]Pentixafor-PET/CT.